X

Create an account to continue reading.

Registered readers have access to our blogs and a limited number of magazine articles
For unlimited access to The Spectator, subscribe below

Registered readers have access to our blogs and a limited number of magazine articles

Sign in to continue

Already have an account?

What's my subscriber number?

Subscribe now from £1 a week

Online

Unlimited access to The Spectator including the full archive from 1828

Print

Weekly delivery of the magazine

App

Phone & tablet edition of the magazine

Spectator Club

Subscriber-only offers, events and discounts
 
View subscription offers

Already a subscriber?

or

Subscribe now for unlimited access

ALL FROM JUST £1 A WEEK

View subscription offers

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating an account – Your subscriber number was not recognised though. To link your subscription visit the My Account page

Thank you for creating your account – To update your details click here to manage your account

X

Login

Don't have an account? Sign up
X

Subscription expired

Your subscription has expired. Please go to My Account to renew it or view subscription offers.

X

Forgot Password

Please check your email

If the email address you entered is associated with a web account on our system, you will receive an email from us with instructions for resetting your password.

If you don't receive this email, please check your junk mail folder.

X

It's time to subscribe.

You've read all your free Spectator magazine articles for this month.

Subscribe now for unlimited access – from just £1 a week

You've read all your free Spectator magazine articles for this month.

Subscribe now for unlimited access

Online

Unlimited access to The Spectator including the full archive from 1828

Print

Weekly delivery of the magazine

App

Phone & tablet edition of the magazine

Spectator Club

Subscriber-only offers, events and discounts
X

Sign up

What's my subscriber number? Already have an account?

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating your account – To update your details click here to manage your account

Thank you for creating an account – Your subscriber number was not recognised though. To link your subscription visit the My Account page

Thank you for creating your account – To update your details click here to manage your account

X

Your subscriber number is the 8 digit number printed above your name on the address sheet sent with your magazine each week.

Entering your subscriber number will enable full access to all magazine articles on the site.

If you cannot find your subscriber number then please contact us on customerhelp@subscriptions.spectator.co.uk or call 0330 333 0050.

You can create an account in the meantime and link your subscription at a later time. Simply visit the My Account page, enter your subscriber number in the relevant field and click 'submit changes'.

Coffee House

Number 10: Government is ‘active in engagement’ over Pfizer bid

6 May 2014

1:28 PM

6 May 2014

1:28 PM

What is the government’s stance on Pfizer’s takeover bid of AstraZeneca? Today the Prime Minister’s official spokesman was asked this – and his answer didn’t shed a great deal of light on the situation. He said the position was ‘active in engagement, with both companies in terms of the importance to the UK of R&D and the science base, with regard to the decision as to whether or not going ahead is the right thing to do for either company and their shareholders, is entirely a matter for the companies, their boards and their shareholders’.

But what if the takeover does turn out to damage jobs and the science base in this country? Would the government remain neutral on the deal in the way that the Prime Minister has suggested, and in the way that his spokesman suggests in the above quote? The spokesman responded:

‘Well, I would say that’s pretty much what I’ve just described in my opening answer in terms of as I say, in terms of assessing the potential link to jobs and the skills base to be very actively engaged in terms of what must be and is a decision for respective boards, entirely a matter for them and not something which the government is involved in.’

[Alt-Text]


He added that the government was ‘making no apology that we want to engage very actively with both companies in terms of as I say the importance of R&D, of skills, of expanding the skills base in the UK, we will keep doing that, but as I said, what is a commercial decision between the shareholders, we believe that is for the shareholder and no-one else and we will continue making that point very clearly.’

This is a funny sort of active engagement. It’s less a rugby player in a scrum and more a spectator shouting a lot from the sidelines while realising he has no influence over the game. The government doesn’t want to interfere in the deal itself, but it wants to be seen to be making sure that Britain gets the best deal. Another nuance is that it doesn’t want to scare away foreign companies that it has tried hard to attract through a competitive tax regime and a world-renowned research base in a part of the world where researchers are keen to live and put down roots. But it also doesn’t want to give the impression that Britain is somehow a valley of assets that vulture-like companies can come along and strip. Its position isn’t clear, really, at all, and that leads to the government looking both meddling and powerless at once.

Give something clever this Christmas – a year’s subscription to The Spectator for just £75. And we’ll give you a free bottle of champagne. Click here.


Show comments
Close